{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:08:49Z","timestamp":1782086929034,"version":"3.54.5"},"reference-count":63,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CHYR"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec><jats:title>:<\/jats:title><jats:p>Chronic kidney disease is a global public health issue, and it has been considered as the epidemic of the 21st century. Therefore, all initiatives addressed to slow down the evolution and complications of this condition should be well received. While the effects of salt reduction on cardiovascular disease have some controversial issues, in chronic kidney disease, such a policy is beneficial in multiple aspects. In chronic kidney disease patients, dietary sodium restriction is regularly recommended to control extracellular fluid expansion, hypertension and cardiovascular risk. Instead, the effects of sodium reduction on chronic kidney disease progression are still controversial. In the last years, potentially beneficial effects of a low sodium diet on chronic kidney disease evolution have emerged. Firstly, recent magnetic resonance-based findings of increased Na depots in skin and muscle associated with renal function, ageing and sodium intake open a vast body of investigation as a potential tool for monitoring effects of sodium restriction. In this narrative review, we also discussed novel aspects of sodium restriction in chronic kidney disease to manage metabolic acidosis as well as renal effects on fibroblast growth factor 23 or gut microbiota. Beyond current evidence, these approaches showed that common findings of kidney failure environment such as sodium -sensitivity, micro-inflammation, arterial stiffness metabolic acidosis and sarcopenia could be delayed controlling dietary sodium. Additional studies are now needed in populations with chronic kidney disease to confirm these new findings, addressed to slow down the evolution and complications of this condition.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1573402116666200615152139","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T14:58:48Z","timestamp":1592233128000},"page":"59-66","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Potential Novel Benefits of Sodium Restriction in Chronic Kidney Disease"],"prefix":"10.2174","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2434-9226","authenticated-orcid":true,"given":"Rodolfo","family":"Valtuille","sequence":"first","affiliation":[{"name":"Department of Clinical Research, Universidad Nacional Guillermo Brown, 2289 Espora Avenue, Burzaco, B1852FZD Buenos Aires,Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1161\/HYPERTENSIONAHA.116.07415","volume":"68","author":"Oh Y.S.","year":"2016","unstructured":"Oh Y.S.; Appel L.J.; Galis Z.S.; National heart, lung, and blood institute working Group report on salt in human health and sickness: Building on the current scientific evidence. Hypertension 2016,68(2),281-288","journal-title":"Hypertension"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1056\/NEJMoa1304127","volume":"371","author":"Mozaffarian D.","year":"2014","unstructured":"Mozaffarian D.; Fahimi S.; Singh G.M.; Global sodium consumption and death from cardiovascular causes. N Engl J Med Global Burden of Diseases Nutrition and Chronic Diseases Expert Group2014,371(7),624-634","journal-title":"N Engl J Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fendo.2016.00164","volume":"7","author":"Kong Y.W.","year":"2016","unstructured":"Kong Y.W.; Baqar S.; Jerums G.; Ekinci E.I.; Sodium and its role in cardiovascular disease - the debate continues. Front Endocrinol (Lausanne) 2016,7,164","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=4","year":"2012","unstructured":"Sodium intake for adults and children Geneva, World Health Organization (WHO) 2012. Available from: WHO2012 https:\/\/www.who.int\/publications-detail\/sodium-intake-for-adults-and-children"},{"key":"ref=5","first-page":"584","volume":"378","author":"Kalantar-Zadeh K.","year":"2018","unstructured":"Kalantar-Zadeh K.; Fouque D.; Nutritional management of chronic kidney disease. N Engl J Med 2018,378(6),584-585","journal-title":"N Engl J Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1053\/j.ajkd.2018.06.016","volume":"73","author":"Koppe L.","year":"2019","unstructured":"Koppe L.; Fouque D.; The role for protein restriction in addition to renin-angiotensin-aldosterone system inhibitors in the management of CKD. Am J Kidney Dis 2019,73(2),248-257","journal-title":"Am J Kidney Dis"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/MNH.0000000000000073","volume":"23","author":"Humalda J.K.","year":"2014","unstructured":"Humalda J.K.; Navis G.; Dietary sodium restriction: A neglected therapeutic opportunity in chronic kidney disease. Curr Opin Nephrol Hypertens 2014,23(6),533-540","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","year":"2013","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group: KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013,3,1-150","journal-title":"Kidney Int Suppl"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1053\/j.ackd.2017.07.003","volume":"24","author":"Ellison D.H.","year":"2017","unstructured":"Ellison D.H.; Treatment of disorders of sodium balance in chronic kidney disease. Adv Chronic Kidney Dis 2017,24(5),332-341","journal-title":"Adv Chronic Kidney Dis"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000355786","volume":"39","author":"Mallamaci F.","year":"2014","unstructured":"Mallamaci F.; Tripepi G.; Salt restriction in chronic kidney disease: A simple need or a must? Kidney Blood Press Res 2014,39(2-3),124-128","journal-title":"Kidney Blood Press Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/01.mnh.0000441151.55320.c3","volume":"23","author":"Titze J.","year":"2014","unstructured":"Titze J.; Sodium balance is not just a renal affair. Curr Opin Nephrol Hypertens 2014,23(2),101-105","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1093\/ndt\/gfv343","volume":"31","author":"Titze J.","year":"2016","unstructured":"Titze J.; Rakova N.; Kopp C.; Dahlmann A.; Jantsch J.; Luft F.C.; Balancing wobbles in the body sodium. Nephrol Dial Transplant 2016,31(7),1078-1081","journal-title":"Nephrol Dial Transplant"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/MNH.0000000000000188","volume":"25","author":"Johnson R.S.","year":"2016","unstructured":"Johnson R.S.; Titze J.; Weller R.; Cutaneous control of blood pressure. Curr Opin Nephrol Hypertens 2016,25(1),11-15","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.kint.2018.09.024","volume":"95","author":"Canaud B.","year":"2019","unstructured":"Canaud B.; Kooman J.; Selby N.M.; Sodium and water handling during hemodialysis: New pathophysiologic insights and management approaches for improving outcomes in end-stage kidney disease. Kidney Int 2019,95(2),296-309","journal-title":"Kidney Int"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.2215\/CJN.00600119","volume":"14","author":"Qian Q.","year":"2019","unstructured":"Qian Q.; Metabolic acidosis in a patient with CKD. Clin J Am Soc Nephrol 2019,14(8),1245-1247","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1053\/j.ajkd.2018.09.004","volume":"73","author":"Bushinsky D.A.","year":"2019","unstructured":"Bushinsky D.A.; Tolerance to sodium in patients with CKD-induced metabolic acidosis: Does the accompanying anion matter? Am J Kidney Dis 2019,73(6),858-865","journal-title":"Am J Kidney Dis"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fendo.2018.00278","volume":"9","author":"Leifheit-Nestler M.","year":"2018","unstructured":"Leifheit-Nestler M.; Haffner D.; Paracrine Effects of FGF23 on the heart. Front Endocrinol (Lausanne) 2018,9,278","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/MNH.0000000000000240","volume":"25","author":"Han X.","year":"2016","unstructured":"Han X.; Quarles L.D.; Multiple faces of fibroblast growth factor-23. Curr Opin Nephrol Hypertens 2016,25(4),333-342","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1053\/j.ajkd.2014.07.022","volume":"65","author":"Humalda J.K.","year":"2015","unstructured":"Humalda J.K.; Heerspink H.J.L.; Kwakernaak A.J.; Fibroblast growth factor 23 and the antiproteinuric response to dietary sodium restriction during renin-angiotensin-aldosterone system blockade. Am J Kidney Dis NIGRAM Consortium2015,65(2),259-266","journal-title":"Am J Kidney Dis"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.12659\/MSM.906489","volume":"24","author":"Hu J.W.","year":"2018","unstructured":"Hu J.W.; Wang Y.; Chu C.; Mu J.J.; Effect of salt intervention on serum levels of fibroblast growth factor 23 (FGF23) in Chinese adults: An intervention study. Med Sci Monit 2018,24,1948-1954","journal-title":"Med Sci Monit"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3389\/fcvm.2019.00136","volume":"6","author":"Polychronopoulou E.","year":"2019","unstructured":"Polychronopoulou E.; Braconnier P.; Burnier M.; New Insights on the role of sodium in the physiological regulation of blood pressure and development of hypertension. Front Cardiovasc Med 2019,6,136","journal-title":"Front Cardiovasc Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/MNH.0000000000000149","volume":"24","author":"Jose P.A.","year":"2015","unstructured":"Jose P.A.; Raj D.; Gut microbiota in hypertension. Curr Opin Nephrol Hypertens 2015,24(5),403-409","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1681\/ASN.2013080905","volume":"25","author":"Ramezani A.","year":"2014","unstructured":"Ramezani A.; Raj D.S.; The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol 2014,25(4),657-670","journal-title":"J Am Soc Nephrol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1159\/000485154","volume":"45","author":"Nerbass F.B.","year":"2018","unstructured":"Nerbass F.B.; Calice-Silva V.; Pecoits-Filho R.; Sodium intake and blood pressure in patients with chronic kidney disease: A salty relationship. Blood Purif 2018,45(1-3),166-172","journal-title":"Blood Purif"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/MNH.0b013e32835b3693","volume":"22","author":"Felder R.A.","year":"2013","unstructured":"Felder R.A.; White M.J.; Williams S.M.; Jose P.A.; Diagnostic tools for hypertension and salt sensitivity testing. Curr Opin Nephrol Hypertens 2013,22(1),65-76","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41440-018-0158-6","volume":"42","author":"Nishiyama A.","year":"2019","unstructured":"Nishiyama A.; Pathophysiological mechanisms of mineralocorticoid receptor-dependent cardiovascular and chronic kidney disease. Hypertens Res 2019,42(3),293-300","journal-title":"Hypertens Res"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/kisup.2012.46","volume":"2","year":"2012","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO Clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int Suppl 2012,2,337-414","journal-title":"Kidney Int Suppl"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1053\/j.ajkd.2013.03.018","volume":"62","author":"Taler S.J.","year":"2013","unstructured":"Taler S.J.; Agarwal R.; Bakris G.L.; KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD. Am J Kidney Dis 2013,62(2),201-213","journal-title":"Am J Kidney Dis"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/ndt\/gft321","volume":"29","author":"Verbeke F.","year":"2014","unstructured":"Verbeke F.; Lindley E.; Van Bortel L.; A European Renal Best Practice (ERBP) position statement on the Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease: An endorsement with some caveats for real-life application. Nephrol Dial Transplant 2014,29(3),490-496","journal-title":"Nephrol Dial Transplant"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1053\/j.ajkd.2014.03.003","volume":"63","author":"Ruzicka M.","year":"2014","unstructured":"Ruzicka M.; Quinn R.R.; McFarlane P.; Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for the management of blood pressure in CKD. Am J Kidney Dis 2014,63(6),869-887","journal-title":"Am J Kidney Dis"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.kint.2018.12.025","volume":"95","author":"Cheung A.K.","year":"2019","unstructured":"Cheung A.K.; Chang T.I.; Cushman W.C.; Conference Participants. Blood pressure in chronic kidney disease: Conclusions from a kidney disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 2019,95(5),1027-1036","journal-title":"Kidney Int"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1056\/NEJMe1407695","volume":"371","author":"Oparil S.","year":"2014","unstructured":"Oparil S.; Low sodium intake--cardiovascular health benefit or risk? N Engl J Med 2014,371(7),677-679","journal-title":"N Engl J Med"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1056\/NEJMsb1607161","volume":"375","author":"Cogswell M.E.","year":"2016","unstructured":"Cogswell M.E.; Mugavero K.; Bowman B.A.; Frieden T.R.; Dietary sodium and cardiovascular disease risk-measurement matters. N Engl J Med 2016,375(6),580-586","journal-title":"N Engl J Med"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1001\/jama.2011.574","volume":"305","author":"Stolarz-Skrzypek K.","year":"2011","unstructured":"Stolarz-Skrzypek K.; Kuznetsova T.; Thijs L.; Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA European Project on Genes in Hypertension (EPOGH) Investigators2011,305(17),1777-1785","journal-title":"JAMA"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1093\/ajh\/hpu028","volume":"27","author":"Graudal N.","year":"2014","unstructured":"Graudal N.; J\u00fcrgens G.; Baslund B.; Alderman M.H.; Compared with usual sodium intake, low- and excessive-sodium diets are associated with increased mortality: A meta-analysis. Am J Hypertens 2014,27(9),1129-1137","journal-title":"Am J Hypertens"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1093\/ajh\/hpt294","volume":"27","author":"Smyth A.","year":"2014","unstructured":"Smyth A.; O\u2019Donnell M.J.; Yusuf S.; Sodium intake and renal outcomes: A systematic review. Am J Hypertens 2014,27(10),1277-1284","journal-title":"Am J Hypertens"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.3390\/nu6114651","volume":"6","author":"McLean R.M.","year":"2014","unstructured":"McLean R.M.; Measuring population sodium intake: A review of methods. Nutrients 2014,6(11),4651-4662","journal-title":"Nutrients"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1681\/ASN.2015010022","volume":"27","author":"He J.","year":"2016","unstructured":"He J.; Mills K.T.; Appel L.J.; Urinary sodium and potassium excretion and CKD progression. J Am Soc Nephrol Chronic Renal Insufficiency Cohort Study Investigators2016,27(4),1202-1212","journal-title":"J Am Soc Nephrol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1136\/heartjnl-2013-303688","volume":"99","author":"de Brito-Ashurst I.","year":"2013","unstructured":"de Brito-Ashurst I.; Perry L.; Sanders T.A.; The role of salt intake and salt sensitivity in the management of hypertension in South Asian people with chronic kidney disease: A randomised controlled trial. Heart 2013,99(17),1256-1260","journal-title":"Heart"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1681\/ASN.2013030285","volume":"24","author":"McMahon E.J.","year":"2013","unstructured":"McMahon E.J.; Bauer J.D.; Hawley C.M.; A randomized trial of dietary sodium restriction in CKD. J Am Soc Nephrol 2013,24(12),2096-2103","journal-title":"J Am Soc Nephrol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/ki.2014.59","volume":"86","author":"Fan L.","year":"2014","unstructured":"Fan L.; Tighiouart H.; Levey A.S.; Beck G.J.; Sarnak M.J.; Urinary sodium excretion and kidney failure in nondiabetic chronic kidney disease. Kidney Int 2014,86(3),582-588","journal-title":"Kidney Int"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2215\/CJN.01120216","volume":"12","author":"Saran R.","year":"2017","unstructured":"Saran R.; Padilla R.L.; Gillespie B.W.; A randomized crossover trial of dietary sodium restriction in stage 3-4 CKD. Clin J Am Soc Nephrol 2017,12(3),399-407","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1001\/jama.2016.4447","volume":"315","author":"Mills K.T.","year":"2016","unstructured":"Mills K.T.; Chen J.; Yang W.; Sodium excretion and the risk of cardiovascular disease in patients with chronic kidney disease. JAMA Chronic Renal Insufficiency Cohort (CRIC) Study Investigators2016,315(20),2200-2210","journal-title":"JAMA"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1053\/j.ajkd.2016.09.008","volume":"69","author":"Leonberg-Yoo A.K.","year":"2017","unstructured":"Leonberg-Yoo A.K.; Sarnak M.J.; Don\u2019t pass the salt: Evidence to support avoidance of high salt intake in CKD. Am J Kidney Dis 2017,69(2),175-178","journal-title":"Am J Kidney Dis"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/ki.2014.269","volume":"87","author":"Dahlmann A.","year":"2015","unstructured":"Dahlmann A.; D\u00f6rfelt K.; Eicher F.; Magnetic resonance-determined sodium removal from tissue stores in hemodialysis patients. Kidney Int 2015,87(2),434-441","journal-title":"Kidney Int"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1161\/HYPERTENSIONAHA.111.00566","volume":"61","author":"Kopp C.","year":"2013","unstructured":"Kopp C.; Linz P.; Dahlmann A.; 23Na magnetic resonance imaging-determined tissue sodium in healthy subjects and hypertensive patients. Hypertension 2013,61(3),635-640","journal-title":"Hypertension"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1681\/ASN.2016060662","volume":"28","author":"Schneider M.P.","year":"2017","unstructured":"Schneider M.P.; Raff U.; Kopp C.; Skin sodium concentration correlates with left ventricular hypertrophy in CKD. J Am Soc Nephrol 2017,28(6),1867-1876","journal-title":"J Am Soc Nephrol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12933-017-0654-z","volume":"17","author":"Karg M.V.","year":"2018","unstructured":"Karg M.V.; Bosch A.; Kannenkeril D.; SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: A randomised controlled trial. Cardiovasc Diabetol 2018,17(1),5","journal-title":"Cardiovasc Diabetol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s00421-017-3647-4","volume":"117","author":"Gerlach D.A.","year":"2017","unstructured":"Gerlach D.A.; Schopen K.; Linz P.; Atrophy of calf muscles by unloading results in an increase of tissue sodium concentration and fat fraction decrease: a 23Na MRI physiology study. Eur J Appl Physiol 2017,117(8),1585-1595","journal-title":"Eur J Appl Physiol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12882-016-0283-x","volume":"17","author":"Mitch W.E.","year":"2016","unstructured":"Mitch W.E.; Remuzzi G.; Diets for patients with chronic kidney disease, should we reconsider? BMC Nephrol 2016,17(1),80","journal-title":"BMC Nephrol"},{"key":"ref=51","first-page":"325","author":"G\u00f3mez Candela C.","year":"2002","unstructured":"G\u00f3mez Candela C.; Sastre Gallego A.; Anexo 6 Unidades F\u00f3rmulas de conversi\u00f3n y principales electrolitos Pesos y medidas 2002,325-326","journal-title":"Anexo 6 Unidades F\u00f3rmulas de conversi\u00f3n y principales electrolitos Pesos y medidas"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1681\/ASN.2017040422","volume":"29","author":"Raphael K.L.","year":"2018","unstructured":"Raphael K.L.; Metabolic acidosis and subclinical metabolic acidosis in CKD. J Am Soc Nephrol 2018,29(2),376-382","journal-title":"J Am Soc Nephrol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.2215\/CJN.13091118","volume":"14","author":"Navaneethan S.D.","year":"2019","unstructured":"Navaneethan S.D.; Shao J.; Buysse J.; Bushinsky D.A.; Effects of treatment of metabolic acidosis in CKD: A systematic review and meta-analysis. Clin J Am Soc Nephrol 2019,14(7),1011-1020","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"272","DOI":"10.2215\/CJN.06190616","volume":"12","author":"Kelly J.T.","year":"2017","unstructured":"Kelly J.T.; Palmer S.C.; Wai S.N.; Healthy dietary patterns and risk of mortality and ESRD in CKD: A meta-analysis of cohort studies. Clin J Am Soc Nephrol 2017,12(2),272-279","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1053\/j.jrn.2017.06.005","volume":"28","author":"Visconti L.","year":"2018","unstructured":"Visconti L.; Cernaro V.; Calimeri S.; The myth of water and salt: From aquaretics to tenapanor. J Ren Nutr 2018,28(2),73-82","journal-title":"J Ren Nutr"},{"key":"ref=56","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aam6474","volume":"10","author":"King A.J.","year":"2018","unstructured":"King A.J.; Siegel M.; He Y.; Inhibition of sodium\/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeability. Sci Transl Med 2018,10(456)","journal-title":"Sci Transl Med"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00424-020-02352-x","volume":"472","author":"Rukavina Mikusic N.L.","year":"2020","unstructured":"Rukavina Mikusic N.L.; Kouyoumdzian N.M.; Choi M.R.; Gut microbiota and chronic kidney disease: Evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis. Pflugers Arch 2020,472(3),303-320","journal-title":"Pflugers Arch"},{"key":"ref=58","doi-asserted-by":"publisher","DOI":"10.3390\/toxins10040155","volume":"10","author":"Koppe L.","year":"2018","unstructured":"Koppe L.; Fouque D.; Soulage C.O.; The role of gut microbiota and diet on uremic retention solutes production in the context of chronic kidney disease. Toxins (Basel) 2018,10(4)","journal-title":"Toxins (Basel)"},{"key":"ref=59","doi-asserted-by":"publisher","DOI":"10.3390\/nu11030496","volume":"11","author":"Mafra D.","year":"2019","unstructured":"Mafra D.; Borges N.; Alvarenga L.; Dietary components that may influence the disturbed gut microbiota in chronic kidney disease. Nutrients 2019,11(3)","journal-title":"Nutrients"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1053\/j.jrn.2019.11.002","volume":"30","author":"Snelson M.","year":"2020","unstructured":"Snelson M.; Biruete A.; McFarlane C.; Campbell K.; A renal clinician\u2019s guide to the gut microbiota. J Ren Nutr 2020,30(5),384-395","journal-title":"J Ren Nutr"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1681\/ASN.2019101049","volume":"31","author":"Coresh J.","year":"2019","unstructured":"Coresh J.; Gansevoort R.T.; Levin A, Jadoul M; on behalf of KDIGO. Current CKD definition takes into account both relative and absolute risk. J Am Soc Nephrol CKD Prognosis Consortium2019,31(2),447-448","journal-title":"J Am Soc Nephrol"},{"key":"ref=62","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/628654","volume":"2015","author":"Bia D.","year":"2015","unstructured":"Bia D.; Galli C.; Valtuille R.; Hydration status is associated with aortic stiffness, but not with peripheral arterial stiffness, in chronically hemodialysed patients. Int J Nephrol 2015,2015","journal-title":"Int J Nephrol"},{"key":"ref=63","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/695263","volume":"2015:695263","author":"Valtuille R","year":"2015","unstructured":"Valtuille R; Casos ME; Fernandez EA; Guinsburg A; Marelli C; Nutritional markers and body composition in hemodialysis patients. Int Sch Res Notices 2015,2015:695263","journal-title":"Int Sch Res Notices"}],"container-title":["Current Hypertension Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573402116666200615152139","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/182816\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573402116666200615152139","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T11:20:48Z","timestamp":1696245648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/182816\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573402116666200615152139","relation":{},"ISSN":["1573-4021"],"issn-type":[{"value":"1573-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-01-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}